Results 131 to 140 of about 19,748 (182)

Prophylactic implantation of cardioverter-defibrillator in patients with advanced light-chain amyloidosis-A pilot study. [PDF]

J Arrhythm
Wei HQ, Wang J, Liang Y, Xia S, Li L, Zhong L.   +5 more
europepmc   +1 more source

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE. [PDF]

Biomedicines
Musigk N, Suwalski P, Müller M, Violano M, Klingel K, Weiner J, Beule D, Landmesser U, Heidecker B.   +8 more
europepmc   +1 more source

How to demonstrate the clinical implication of prophylactic implantable cardioverter-defibrillator in patients with advanced light chain amyloidosis. [PDF]

J Arrhythm
Kataoka N, Imamura T.
europepmc   +1 more source

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center. [PDF]

Hematol Oncol
Dima D, Goel U, Ullah F, Faiman B, Basali D, Mazzoni S, Williams LS, Samaras C, Valent J, Anwer F, Khouri J, Raza S.   +11 more
europepmc   +1 more source

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies. [PDF]

J Clin Med
Zhou P, Mansukhani MM, Yeh R, Lu J, Xia H, Koganti L, Pang J, Toskic D, Scalia S, Ma X, Lee LX, Wong SW, Chung A, Tuchman SA, Fogaren T, Coady Lyons N, Varga C, Lentzsch S, Comenzo RL.   +18 more
europepmc   +1 more source

Periorbital Purpura as a Key Diagnostic Clue in Immunoglobulin Light Chain Amyloidosis. [PDF]

JMA J
Miyaue K, Isono H.
europepmc   +1 more source

Amyloidosis With No Light Chain Deposit

American Journal of Kidney Diseases, 2016
openaire   +1 more source

Current landscape of clinical management for systemic light chain amyloidosis. [PDF]

Future Cardiol
Staron A, Sanchorawala V.
europepmc   +1 more source

Daratumumab plus bortezomib and dexamethasone (Dara-VD) in newly diagnosed Mayo 2004 stage IIIA and IIIB light-chain amyloidosis: Long-term follow-up results from a prospective phase 2 study. [PDF]

Br J Haematol
Xue-Min G, Chengyang X, Ya-Juan G, Ai G, Yi X, Long C, Kai-Ni S, Jian L.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Light-chain cardiac amyloidosis

Current Problems in Cancer, 2017
Cardiac amyloidosis is an underrecognized condition, in which delays to diagnosis have great implications on management options, prognosis, and morbidity. Once cardiac tissue is infiltrated by amyloid fibrils, there is a cascade of pathologic changes that can display an array of clinical manifestations, from impaired relaxation of the ventricular ...
Anit K, Mankad, Isata, Sesay, Keyur B, Shah   +2 more
openaire   +2 more sources